Literature DB >> 16760479

Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo.

Monica Agromayor1, Juan Martin-Serrano.   

Abstract

The "class E" vacuolar protein sorting (VPS) pathway mediates sorting of ubiquitinated cargo into the forming vesicles of the multivesicular bodies (MVB), and it is essential for down-regulation of signaling by growth factors and budding of enveloped viruses such as Ebola and HIV-1. Work in yeast has identified DOA4 as a gene that is recruited by the class E machinery to remove ubiquitin from the endosomal cargo before it is incorporated into MVB vesicles, but the identity of the mammalian counterpart is unclear. Here we report the interaction of AMSH (associated molecule with the SH3 domain of STAM), an endosomal deubiquitinating enzyme, with the endodomal sorting complex required for transport (ESCRT-III) subunits CHMP1A, CHMP1B, CHMP2A, and CHMP3. We also show that a catalytically inactive AMSH inhibits retroviral budding in a dominant-negative manner and induces the accumulation of ubiquitinated forms of an endosomal cargo, namely murine leukemia virus Gag. Finally, VPS4 and AMSH compete for binding to the C-terminal regions of CHMP1A and CHMP1B, revealing a coordinated interaction with ESCRT-III. Taken together, these results are consistent with a role of AMSH in the deubiquitination of the endosomal cargo preceding lysosomal degradation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760479     DOI: 10.1074/jbc.M513803200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

Review 1.  The ESCRT complexes.

Authors:  James H Hurley
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-07-23       Impact factor: 8.250

Review 2.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

3.  Arabidopsis ALIX is required for the endosomal localization of the deubiquitinating enzyme AMSH3.

Authors:  Kamila Kalinowska; Marie-Kristin Nagel; Kaija Goodman; Laura Cuyas; Franziska Anzenberger; Angela Alkofer; Javier Paz-Ares; Pascal Braun; Vicente Rubio; Marisa S Otegui; Erika Isono
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

4.  Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins.

Authors:  Robert E Dejournett; Ryuji Kobayashi; Shujuan Pan; Chuanfen Wu; Laurence D Etkin; Richard B Clark; Oliver Bögler; Jian Kuang
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

Review 5.  ESCRT complexes and the biogenesis of multivesicular bodies.

Authors:  James H Hurley
Journal:  Curr Opin Cell Biol       Date:  2008-01-28       Impact factor: 8.382

6.  The Arabidopsis deubiquitinating enzyme AMSH3 interacts with ESCRT-III subunits and regulates their localization.

Authors:  Anthi Katsiarimpa; Franziska Anzenberger; Nicole Schlager; Susanne Neubert; Marie-Theres Hauser; Claus Schwechheimer; Erika Isono
Journal:  Plant Cell       Date:  2011-08-02       Impact factor: 11.277

Review 7.  Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.

Authors:  Hiroshi Ageta; Kunihiro Tsuchida
Journal:  Cell Mol Life Sci       Date:  2019-07-30       Impact factor: 9.261

8.  No strings attached: the ESCRT machinery in viral budding and cytokinesis.

Authors:  Bethan McDonald; Juan Martin-Serrano
Journal:  J Cell Sci       Date:  2009-07-01       Impact factor: 5.285

9.  Structural basis for autoinhibition of ESCRT-III CHMP3.

Authors:  Suman Lata; Manfred Roessle; Julianna Solomons; Marc Jamin; Heinrich G Gottlinger; Dmitri I Svergun; Winfried Weissenhorn
Journal:  J Mol Biol       Date:  2008-03-20       Impact factor: 5.469

Review 10.  Regulation of Vps4 ATPase activity by ESCRT-III.

Authors:  Brian A Davies; Ishara F Azmi; David J Katzmann
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.